Cardiac Interventions Today

Cardiac Interventions Today is a specialized publication focused on delivering in-depth information about the newest advancements in technology, methods, clinical research, and regulations related to coronary and cardiac interventions. Launched in March 2007, this publication features a diverse range of subjects in a user-friendly format. Each issue includes articles that present different viewpoints on pressing clinical issues, detailed interviews with leading physicians, summaries of existing technologies, updates from the industry, and valuable insights into the challenges faced by today's interventional cardiology practices.

National, Trade/B2B

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#800794

United States

#305781

Health/Medicine

#2215

Traffic sources

Monthly visitors

Articles

Aortic Regurgitation Frontier: Management Options and Future Directions

Oct 23, 2024 | citoday.com | Mohammed Ahmed |Nishath Quader |Tsuyoshi Kaneko |Alan Zajarias |Marc Sintek

Aortic regurgitation (AR) is a condition where the aortic valve fails to close properly, leading to backward flow of blood into the left ventricle.
The Frontier of Tricuspid Imaging: Utility of TEE and ICE

Oct 23, 2024 | citoday.com | Nishath Quader |Tsuyoshi Kaneko |Alan Zajarias

Transcatheter tricuspid valve interventions (TTVIs) are transforming the management of severe tricuspid regurgitation (TR), offering a promising alternative for high-risk patients who are not suitable candidates for traditional surgical options. The success of TTVI procedures depends on the accuracy and comprehensiveness of imaging from preprocedural assessment, to intraprocedural guidance, to postprocedure follow-up.
Valvular Calcium: Calcium in Mitral Valves

Aug 16, 2024 | citoday.com | Luke P. Dawson |Rahul Sharma

There have been remarkable advances in transcatheter therapies for structural heart disease during the last 20 years, resulting in an assortment of treatment options for patients with severe valvular heart disease.
Valvular Calcium: The Importance of Calcium in Aortic Stenosis to Inform Shared Decision-Making Discussions

Aug 16, 2024 | citoday.com | Megan Coylewright

As the heart team is focusing on the lifetime management of aortic valve disease and decision-making in younger patients with aortic stenosis (AS), considerations about calcium management are as important as ever.
May/June 2024 Supplement - Cardiac Interventions Today

Jun 25, 2024 | citoday.com | Priscilla Wessly |Renuka Jain |Sabine Bleiziffer |Puja B. Parikh

May/June 2024 Supplement It’s Time to Make a Difference for Women With Aortic Stenosis Learn about the underdiagnosis, under-referral, and undertreatment of women with aortic stenosis and how we approach this significant healthcare challenge. Sponsored by Medtronic
Coronary Atherectomy

Jun 24, 2024 | citoday.com | Nadia R. Sutton

Techniques, tips, and tricks to help you make a difference.
Transcatheter Tricuspid Valve Replacement With the Evoque Valve

Jun 21, 2024 | citoday.com | Aakriti Gupta |Moody Makar |Raj R. Makkar

Severe tricuspid regurgitation (TR) is a prevalent valvular heart disease, particularly among older populations and those with heart failure, resulting in high mortality with a 5-year survival rate below 30% and increased hospitalizations related to heart failure and atrial fibrillation.1 Although the majority of TR cases are functional, caused by structural changes in the heart such as annular dilatation and leaflet tethering, surgical interventions remain underutilized due to high...
Embolic Protection During TAVR: Where Do We Go After PROTECTED TAVR?

Apr 24, 2024 | citoday.com | Amit N Vora |Yousif Ahmad |Alexandra J. Lansky

Stroke is one of the most feared complications after transcatheter aortic valve replacement (TAVR) and is associated with significant morbidity, mortality, and substantial economic impact. Contemporary clinically significant stroke rates range from 2% to 4%. However, the incidence of stroke often belies the true degree of neurologic injury, with most patients demonstrating perfusion abnormality after TAVR.
Embolic Protection During TAVR: Where Do We Go After PROTECTED TAVR?

Apr 24, 2024 | citoday.com | Amit N Vora |Yousif Ahmad |Alexandra J. Lansky

Stroke is one of the most feared complications after transcatheter aortic valve replacement (TAVR) and is associated with significant morbidity, mortality, and substantial economic impact. Contemporary clinically significant stroke rates range from 2% to 4%. However, the incidence of stroke often belies the true degree of neurologic injury, with most patients demonstrating perfusion abnormality after TAVR.
Modern Clinical Trials Spotlight

Oct 24, 2023 | citoday.com | Ori Ben-Yehuda

In the field of interventional cardiology on the whole, we are fortunate to have seen a recent wave of strong technologic development, with robust clinical evidence to support many coronary, valvular, structural, and other applications. Physician-scientists are represented throughout our leadership, and the demand for current data is a norm. Fortunately, we recognize that just as our techniques and technologies evolve, so too must our ability to evaluate them.